Pulmonx Corp — Form 8-K
Filed October 27, 2026 · analyzed by the 8-K Agent
8-K
▲ Likely positive
significance 48/100
What the filing says
Pulmonx reported Q3 2026 worldwide revenue of $22.8M (up 6% YoY from $21.5M), with U.S. revenue at $14.9M (+7%) and international at $7.9M (+5%). Net loss improved 40% to $8.4M ($0.19/share) from $14.0M ($0.34/share) YoY; Adjusted EBITDA loss fell 57% to $3.5M from $8.2M. Gross margin held at 76%. Cash position: $52.7M as of Sept 30. FY2026 guidance unchanged at $90-92M revenue; operating expenses now guided $108-109M; expected cash burn $22M for full year.
Why this rating
Positive momentum (return to growth, 40% net loss reduction) is material for a ~$101M company, but absolute scale remains small; Q3 revenue $22.8M annualizes to ~$91M, near-term guidance achievable. Cash runway adequate but finite ($22M burn expected full year leaves ~$48M by year-end). Not transformational but shows stabilization.
See more from October 27, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.